Procarta awarded £7.4M for microbial treatment

  25 September 2019

The company, which has discovered a new type of antimicrobial that kills bacteria by blocking their gene expression, was awarded the funding by CARB-X, a global partnership dedicated to accelerating early antimicrobial R&D.

Further reading: Laboratory News
Author(s): Laboratory News
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

Register

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed